A Phase 3 Trial of Brepocitinib in Dermatomyositis

Journal:

The New England Journal of Medicine

Published:

2026-03-29

DOI:

10.1056/nejmoa2503531

Affiliations:

45

Authors:

41

Go to article

Institutions	Authors	Share
Priovant Therapeutics, United States of America (USA)	2.500000	0.06
University of California, Irvine (UCI), United States of America (USA)	2.000000	0.05
The University of Chicago (UChicago), United States of America (USA)	2.000000	0.05
Johns Hopkins University (JHU), United States of America (USA)	2.000000	0.05
University of Florida (UF), United States of America (USA)	1.000000	0.02
University of Minnesota (UMN), United States of America (USA)	1.000000	0.02
University of Cincinnati (UC), United States of America (USA)	1.000000	0.02
LSU Health Sciences Center New Orleans (LSUHSC-NO), United States of America (USA)	1.000000	0.02
Institute of Rheumatology, Czech Republic	1.000000	0.02
Mayo Clinic - Scottsdale, United States of America (USA)	1.000000	0.02
University of California, San Francisco (UCSF), United States of America (USA)	1.000000	0.02
Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, United States of America (USA)	1.000000	0.02
New York University (NYU), United States of America (USA)	1.000000	0.02
Mayo Clinic's Campus in Florida, United States of America (USA)	1.000000	0.02
University of California, Los Angeles (UCLA), United States of America (USA)	1.000000	0.02
Mass General Brigham, United States of America (USA)	1.000000	0.02
Augusta University, United States of America (USA)	1.000000	0.02
Seoul National University (SNU), South Korea	1.000000	0.02
The University of Texas at Austin (UT Austin), United States of America (USA)	1.000000	0.02
Emory University, United States of America (USA)	1.000000	0.02
Kaohsiung Chang Gung Memorial Hospital, Chang Gung Medical Foundation, Taiwan	1.000000	0.02
University of Pittsburgh (Pitt), United States of America (USA)	1.000000	0.02
Tulane University, United States of America (USA)	1.000000	0.02
University of Kansas Medical Center (KUMC), United States of America (USA)	1.000000	0.02
Stanford University, United States of America (USA)	1.000000	0.02
Rheumatology Associates of Oklahoma, United States of America (USA)	1.000000	0.02
Neuromuscular Clinic and Research Center, United States of America (USA)	1.000000	0.02
Cleveland Clinic, United States of America (USA)	1.000000	0.02
Baylor College of Medicine (BCM), United States of America (USA)	1.000000	0.02
Mayo Clinic, United States of America (USA)	1.000000	0.02
University of Debrecen, Hungary	1.000000	0.02
Children's Hospital of Philadelphia (CHOP), United States of America (USA)	0.500000	0.01
Manchester Academic Health Science Centre (MAHSC), United Kingdom (UK)	0.500000	0.01
The University of Manchester (UoM), United Kingdom (UK)	0.500000	0.01
Hospital Clínico Universidad de Chile, Chile	0.500000	0.01
Corporal Michael J. Crescenz VA Medical Center (CMCVAMC), United States of America (USA)	0.500000	0.01
University of Pennsylvania (Penn), United States of America (USA)	0.500000	0.01
Unidade Local de Saúde Santa Maria (ULSSM), Portugal	0.500000	0.01
Programa Doutoral do Centro Académico de Medicina de Lisboa (CAML), Portugal	0.500000	0.01
International Center for Clinical Studies, Chile	0.500000	0.01
Hospital for Special Surgery (HSS), United States of America (USA)	0.500000	0.01
Weill Cornell Medicine, United States of America (USA)	0.500000	0.01

Interested in Oncology and Carcinogenesis?